COPD Assessment Test (CAT)
Quantifies impact of COPD symptoms on patients' overall health.
0 points
CAT Score
Low
Health impact
Recommend smoking cessation, preventive care, reduced exposure to exacerbation risk factors, LAMA, LABA, and rescue inhalers. ICS can be considered in Group E patients with elevated blood eosinophils.
Dr. Paul W. Jones
About the creator
Paul W. Jones, MD, PhD, is the global medical expert for the respiratory franchise at GSK. He was previously a professor of respiratory medicine and a consultant physician at St George's, University of London in London, UK. Dr. Jones’ primary research is focused on symptom measurement and cognitive outcome of COPD.
To view Dr. Paul W. Jones's publications, visit PubMed
Are you Dr. Paul W. Jones? Send us a message to review your photo and bio, and find out how to submit Creator Insights!
MDCalc loves calculator creators – researchers who, through intelligent and often complex methods, discover tools that describe scientific facts that can then be applied in practice. These are real scientific discoveries about the nature of the human body, which can be invaluable to physicians taking care of patients.
Content Contributors
- Sachin Patel, MD